Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((cost AND effectiveness) OR (human AND papillomavirus) OR (vaccination) OR (human AND papilloma AND virus AND vaccine)):

Search results

Items: 1 to 20 of 285882

1.

Cost-effectiveness of postoperative rehabilitation after surgery for lumbar disc herniation: an analysis based on a randomized controlled trial.

Paulsen RT, Sørensen J, Carreon LY, Andersen MØ.

J Neurosurg Spine. 2020 Jan 17:1-8. doi: 10.3171/2019.11.SPINE191003. [Epub ahead of print]

PMID:
31952034
2.

Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps.

Chin T, Buckee CO, Mahmud AS.

Epidemics. 2020 Jan 9;30:100385. doi: 10.1016/j.epidem.2020.100385. [Epub ahead of print]

PMID:
31951876
3.

Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons.

Machado CM, de Souza ACMF, Romano CM, Dos Santos Freire W, Costa ÂA, Figueiredo WM, Pannuti CS, Luna EJA.

Braz J Infect Dis. 2020 Jan 14. pii: S1413-8670(19)30494-5. doi: 10.1016/j.bjid.2019.12.005. [Epub ahead of print]

PMID:
31951818
4.

A critical analysis of serogroup B meningococcal disease burden in Brazil (2001-2015): implications for public health decisions.

Chicuto LAD, de Moraes C, Cássio de Moraes J, Sáfadi MAP.

Hum Vaccin Immunother. 2020 Jan 17:1-6. doi: 10.1080/21645515.2019.1700710. [Epub ahead of print]

PMID:
31951784
5.

Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation.

Shafie AA, Ahmad N, Naidoo J, Foo CY, Wong C, Pugh S, Tan KK.

Hum Vaccin Immunother. 2020 Jan 17:1-9. doi: 10.1080/21645515.2019.1701911. [Epub ahead of print]

PMID:
31951782
6.

Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.

Costantini M, Callegaro A, Beran J, Berlaimont V, Galgani I.

Hum Vaccin Immunother. 2020 Jan 17:1-6. doi: 10.1080/21645515.2019.1700712. [Epub ahead of print]

PMID:
31951780
7.

Cost-effectiveness of cladribine tablets versus fingolimod in patients with highly active relapsing multiple sclerosis in Portugal.

Pinheiro B, Guerreiro R, Costa J, Miguel LS.

J Med Econ. 2020 Jan 17:1. doi: 10.1080/13696998.2020.1717499. [Epub ahead of print]

PMID:
31951777
8.

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial.

Valéa I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, Owusu Boateng H, Some AM, Buabeng P, Vekemans J, Kotey A, Vandoolaeghe P, Cullinane M, Traskine M, Ouedraogo F, Sambian D, Lievens M, Tahita MC, Jongert E, Lompo P, Idriss A, Borys D, Ouedraogo S, Prempeh F, Schuerman L, Sorgho H, Agbenyega T.

Hum Vaccin Immunother. 2020 Jan 17:1-7. doi: 10.1080/21645515.2019.1695457. [Epub ahead of print]

PMID:
31951771
9.

Cost-effectiveness of atezolizumab versus docetaxel and nivolumab in the treatment of non-small cell lung cancer as a second line in France.

Sivignon M, Roze S, Plommet N, Felizzi F, Paracha N, Mazaleyrat B, Perol M.

J Med Econ. 2020 Jan 17:1. doi: 10.1080/13696998.2020.1718156. [Epub ahead of print]

PMID:
31951770
10.

Hamster neogenin, a host-cell protein contained in a respiratory syncytial virus candidate vaccine, induces antibody responses in rabbits but not in clinical trial participants.

Steff AM, Cadieux-Dion C, de Lannoy G, Prato MK, Czeszak X, André B, Ingels DC, Louckx M, Dewé W, Picciolato M, Maleux K, Fissette L, Dieussaert I.

Hum Vaccin Immunother. 2020 Jan 17:1-11. doi: 10.1080/21645515.2019.1693749. [Epub ahead of print]

PMID:
31951765
11.

Metered-dose inhalers vs nebulization for the delivery of albuterol in pediatric asthma exacerbations: A cost-effectiveness analysis in a middle-income country.

Rodriguez-Martinez CE, Sossa-Briceño MP, Castro-Rodriguez JA.

Pediatr Pulmonol. 2020 Jan 17. doi: 10.1002/ppul.24650. [Epub ahead of print]

PMID:
31951679
12.

Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.

Wang H, Hoffman C, Yang X, Clapp B, Pascual DW.

PLoS Pathog. 2020 Jan 17;16(1):e1008176. doi: 10.1371/journal.ppat.1008176. eCollection 2020 Jan.

PMID:
31951645
13.

Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.

Mupere E, Babikako HM, Okaba-Kayom V, Mutyaba RB, Mwisaka MN, Tenywa E, Lule A, Aceng JR, Mpanga-Kaggwa F, Matseketse D, Aga E.

PLoS One. 2020 Jan 17;15(1):e0218239. doi: 10.1371/journal.pone.0218239. eCollection 2020.

PMID:
31951608
14.

Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination.

Krammer F, Li L, Wilson PC.

Cell Host Microbe. 2019 Dec 11;26(6):712-713. doi: 10.1016/j.chom.2019.11.006.

PMID:
31951584
15.

Advancing the learning health system by incorporating social determinants.

Palakshappa D, Miller DP Jr, Rosenthal GE.

Am J Manag Care. 2020 Jan 1;26(1):e4-e6.

PMID:
31951360
16.

Detection and molecular characterization of uncommon rotavirus group A genotype G12 among hospitalized children in Chennai.

Arun P, Krishnasami K, Gunasekeran P, Fathima G, Padmanabhan V.

Turk J Pediatr. 2019;61(2):209-216. doi: 10.24953/turkjped.2019.02.009.

PMID:
31951330
17.

Clinical findings and genetic analysis of the patients with IL-12Rβ1 deficiency from southeast Turkey.

Doğruel D, Gündeşlioğlu ÖÖ, Yılmaz M, Alabaz D, Altıntaş DU, Kocabaş E.

Turk J Pediatr. 2019;61(2):174-179. doi: 10.24953/turkjped.2019.02.004.

PMID:
31951326
18.

A Smartphone App Designed to Help Cancer Patients Stop Smoking: Results From a Pilot Randomized Trial on Feasibility, Acceptability, and Effectiveness.

Bricker JB, Watson NL, Heffner JL, Sullivan B, Mull K, Kwon D, Westmaas JL, Ostroff J.

JMIR Form Res. 2020 Jan 17;4(1):e16652. doi: 10.2196/16652.

PMID:
31951215
19.

Vaccinations in infants born preterm: An update.

Sioriki AA, Gkentzi D, Papadimitriou E, Dimitriou G, Karatza A.

Curr Pediatr Rev. 2020 Jan 15. doi: 10.2174/1573396316666200116094459. [Epub ahead of print]

PMID:
31951184
20.

NANOTHERAPIES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) DISEASE: RECENT ADVANCEMENTS AND CHALLENGES.

Rapalli VK, Gorantla S, Waghule T, Mahmood A, Singh PP, Dubey SK, Saha RN, Singhvi G.

Recent Pat Drug Deliv Formul. 2020 Jan 16. doi: 10.2174/1872211314666200117095917. [Epub ahead of print]

PMID:
31951173

Supplemental Content

Loading ...
Support Center